











Objective: Pleural effusions after the Fontan operation contribute significantly to
morbidity and prolonged hospitalization. This study investigates the association
between selected preoperative, operative, and postoperative variables and persistent
pleural effusions after the extracardiac Fontan procedure.
Methods: We conducted a retrospective study of extracardiac Fontan procedures.
The variables analyzed as potential risk factors included age and weight at the time
of the operation, anatomic diagnosis, preoperative oxygen saturation, mean pulmo-
nary artery pressure, ventricular end-diastolic pressure, presence of an accessory
source of pulmonary blood flow, presence of significant aortopulmonary collateral
vessels, presence of fenestration, cardiopulmonary bypass time, conduit size, post-
operative pulmonary artery pressure, use of angiotensin-converting enzyme inhib-
itors, and presence of postoperative infection. The outcome measures evaluated
were duration and volume of chest tube drainage after surgical intervention.
Results: From June 1997 to August 2002, 100 consecutive patients underwent the
extracardiac Fontan procedure. The median age at operation was 3.1 years. The
median duration of chest tube drainage was 10 days, and the median volume of
drainage was 14.7 mL · kg1 · d1. As determined by means of multivariate
analysis, significant risk factors for pleural effusions lasting more than 2 weeks were
lower preoperative oxygen saturation (P  .011) and the presence of postoperative
infections (P  .003). Significant risk factors for pleural effusions draining at more
than 20 mL · kg1 · d1 were lower preoperative oxygen saturation (P  .005),
smaller conduit size (P  .04), and longer duration of cardiopulmonary bypass (P
 .004).
Conclusions: Lower preoperative oxygen saturation, presence of postoperative
infection, smaller conduit size, and longer duration of cardiopulmonary bypass were
associated with persistent pleural effusions after the extracardiac Fontan procedure.
Modifications of some of these risk factors might influence the duration and volume
of pleural drainage after surgical intervention.
From the Division of Cardiology,a the Di-
vision of Cardiothoracic Surgery,b and the
Department of Pediatrics,c Children’s Hos-
pital Los Angeles, University of Southern
California, Los Angeles, Calif.
Received for publication June 20, 2003;
revisions received Aug 31, 2003; accepted
for publication Sept 11, 2003.
Address for reprints: Anuja Gupta, MD,
10621 Ashton Ave, Los Angeles, CA
90024 (E-mail: agupta@chla.usc.edu).
J Thorac Cardiovasc Surg 2004;127:1664-9
0022-5223/$30.00
Copyright © 2004 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2003.09.011
1664 The Journal of Thoracic and Cardiovascular Surgery ● June 2004
CH
D
The Fontan procedure for correction of single-ventricle congenital heart lesions has under-gone several modifications in the recentpast.1,2 Some of these changes have resultedin dramatically improved postoperative mor-tality and some sources of morbidity.3-5 The
extracardiac modification of the Fontan procedure is widely
recognized as the approach with the greatest potential for
optimizing postoperative results.1-5 Hemodynamically, it
offers the most efficient design for preserving mechanical
energy of laminar blood flow and avoiding turbulence and
stasis in the Fontan circulation.6,7 However, persistent pleu-
ral effusions continue to be a significant source of morbidity
in the postoperative period, and previous studies have dem-
onstrated this problem to occur in 13% to 39% of patients
after surgical intervention.3,8
The extracardiac Fontan procedure is the standard surgi-
cal treatment for the correction of single-ventricle lesions at
our institution, and persistent pleural effusions are the most
troublesome complication in the early postoperative period
in our experience. The risk factors that contribute to persis-
tent pleural effusions after the extracardiac Fontan proce-
dure have not been well established. The objective of this
study was to evaluate the prevalence of persistent pleural
effusions at our institution and to examine the role of select
preoperative, operative, and postoperative variables that
might influence the risk of this complication after the ex-
tracardiac Fontan procedure.
Methods
Study Design and Subjects
All patients undergoing an extracardiac Fontan procedure between
1997 and 2002 were identified through our institutional surgical
database. Retrospective chart review was then conducted to obtain
specific detailed information about the preoperative, operative, and
postoperative clinical course associated with the Fontan procedure.
Table 1 describes the demographic and relevant clinical informa-
tion of the study subjects. The study was approved by the institu-
tional review board at Children’s Hospital Los Angeles.
Outcome Measures
The main outcomes of interest were duration and volume of
pleural drainage after the Fontan procedure. The chest tube output
after the operation was selected as a surrogate measure of pleural
drainage. The duration of chest tube output was measured in days
from the date of the operation to the final removal of the chest tube.
The volume was measured as the average amount of chest tube
output expressed in milliliters per kilogram per day. Persistent
pleural effusions were defined as pleural effusions lasting more
than 2 weeks after the operation or draining more than an average
of 20 mL · kg1 · d1. The criteria for persistence of pleural
effusions were selected after review of existing literature and on
the basis of clinical practice. No differentiation was made between
chylous and nonchylous effusions.
Variables Analyzed
The variables selected as potential predictors of the outcome
measures consisted of 3 main categories:
1. Preoperative: patient demographic characteristics, including
age and weight at the time of the operation, and relevant
clinical characteristics, including dominant right versus left
morphology of the single ventricle, preoperative oxygen
saturation, ventricular end-diastolic pressure, mean pulmo-
nary artery pressure, presence of an accessory source of
pulmonary blood flow, and presence of significant aortopul-
monary collateral vessels. We were unable to access cinean-
giograms for several patients in the study, and therefore the
presence or absence of significant aortopulmonary collateral
vessels was determined by means of review of the preoper-
ative cardiac catheterization report alone. Hence specific
grading of aortopulmonary collateral vessels for this study
was not possible.
2. Operative: presence of fenestration of the extracardiac baffle,
size of the conduit or graft used for construction of the
extracardiac baffle, and duration of cardiopulmonary bypass.
3. Postoperative: postoperative pulmonary artery pressure (cen-
tral venous pressure), use of angiotensin-converting enzyme
(ACE) inhibitors, and presence or absence of postoperative
infection. The postoperative pulmonary artery pressure was
summarized as the mean central venous pressure recorded at
6, 12, and 24 hours after the operation. Postoperative infec-
tion included bacterial or fungal infections in the blood or the
respiratory tract. These infections were diagnosed in the
period between the operation and before discharge and con-
firmed by means of positive microbiologic culture results.
The above variables were selected on the basis of a review of
previous studies8-30 in the literature regarding risk factors for
persistent pleural effusions after the Fontan procedure.
Statistical Analysis
We tested the hypothesis of whether the duration and volume of
pleural drainage after the Fontan procedure was significantly as-
sociated with the selected preoperative, operative, or postoperative
TABLE 1. Demographic and clinical information of 100




Female sex n (%) 37 (37)
Median age, y (range) 3.1 years (1.39-17.56)
Median weight, kg (range) 13.8 kg (9.5-93)
Clinical diagnosis (n  100)
Hypoplastic left heart syndrome 39
Tricuspid atresia 20
Pulmonary atresia with intact
ventricular septum
20
Hypoplastic left ventricle 9
Double-inlet left ventricle 8
Ebstein anomaly 3
Double-outlet right ventricle 1
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variables. After review of the data, we performed descriptive,
univariate, and multivariate analyses. Linear and logistic regres-
sion analysis was used to identify the risk factors that were
significantly predictive of the 2 main outcome measures. For linear
regression, the outcomes were expressed as the total number of
days and the total volume of pleural drainage. For logistic regres-
sion, the outcomes were expressed as pleural drainage lasting
greater than 14 days and drainage of more than 20 mL · kg1 · d1.
All statistical analyses were performed with the STATA statistical
software package.
Operative Technique
A modified Fontan circulation was completed on cardiopulmonary
bypass by using the extracardiac technique. An expanded polytet-
rafluoroethylene interposition graft was used in all cases. Unless a
concomitant intracardiac procedure was required, aortic cross-
clamping was not used. After the patient was weaned from bypass,
Fontan hemodynamics were evaluated. If the central venous pres-
sure was greater than 18 mm Hg, with a transpulmonary gradient
of more than 12 mm Hg, placement of a fenestration was consid-
ered. This was performed by means of a direct side-to-side anas-
tomosis of the extracardiac baffle with the right atrial free wall.
Preoperative steroids and aprotinin were used in all cases. Modi-
fied ultrafiltration was not used. The postoperative regimen for
anticoagulation consisted of aspirin with or without warfarin.
Results
Between 1997 and 2002, 100 extracardiac Fontan proce-
dures were performed at our institution. Ninety-seven
(97%) patients underwent the extracardiac Fontan proce-
dure as the first Fontan operation. Three (3%) patients had
previously undergone other modifications of the Fontan
procedure and subsequently received revision to the extra-
cardiac Fontan procedure. The survival to hospital dis-
charge after the Fontan operation was 100%. No patient
required takedown of the Fontan procedure for poor post-
operative hemodynamics. Ninety-seven (97%) patients had
undergone a bidirectional Glenn shunt before the Fontan
operation. Twenty-four (24%) patients had the presence of
an accessory source of pulmonary blood flow in addition to
the Glenn shunt. Fourteen of these were in the form of
modified Blalock-Taussig shunts, and the remaining 10 had
antegrade main pulmonary arterial flow.
The median duration of chest tube output after the oper-
ation was 10 days (range, 3-71 days), and the median
volume was 14.7 mL · kg1 · d1 (range, 2-37.5 mL · kg1
· d1). Thirty-seven (37%) patients had pleural drainage
lasting greater than 2 weeks, and 30 (30%) patients had
pleural drainage exceeding 20 mL · kg1 · d1. Eighteen
(18%) patients required placement of additional chest tubes
for reaccumulation of pleural effusions after removal of
previous chest tubes. Eleven (11%) patients required read-
mission for pleural effusions after hospital discharge. The
median hospital length of stay after the operation was 12
days (range, 4-78 days).
Tables 1 and 2 demonstrate demographic and descriptive
information of the variables that were evaluated for persis-
tent pleural effusions after the extracardiac Fontan proce-
dure. Table 3 lists the risk factors that were found to be
significantly (P  .05) associated with prolonged duration
(2 weeks) or increased volume (20 mL · kg1 · d1) of
TABLE 2. Variables analyzed for persistent pleural effu-
sions after the extracardiac Fontan procedure
Variable
Preoperative
Dominant left ventricular lesions 49 (49%)
Pulmonary artery pressure (mm Hg) 12 (5-20.5)
Preoperative oxygen saturation 87 (70%-97%)
Ventricular end-diastolic pressure 8.5 (2-16)
Presence of significant AP
collateral vessels
17 (17%)











Cardiac bypass time (min) 41 (17-126)
Postoperative
Pulmonary artery pressure (mm Hg) 13 (4-22)
Use of ACE inhibitors 87 (87%)
Presence of infection 16 (16%)
Values are given as median (range) or number (percentage). AP, Aorto-
pulmonary; ACE, angiotensin-converting enzyme.
TABLE 3. Risk factors that were statistically significantly
(P < .05) associated with persistent pleural effusions after
the extracardiac Fontan procedure
Variable P value
Prolonged duration of pleural drainage (2 wk)
Multivariate analysis
Lower preoperative oxygen saturation .011
Presence of postoperative infection .003
Univariate analysis
Dominant right ventricular lesions .040
Use of ACE inhibitors postoperatively .030
Excessive volume of pleural drainage (20 mL ·
kg1 · d1)
Multivariate analysis
Longer cardiopulmonary bypass time .005
Smaller graft size .040
Lower preoperative oxygen saturation .004
Univariate analysis
Younger age .050
Higher preoperative pulmonary artery pressure .040
ACE, Angiotensin-converting enzyme.
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pleural drainage, as determined by means of statistical anal-
ysis. In the multivariate analysis lower preoperative oxygen
saturation (P  .011) and the presence of postoperative
infections (P  .003) were significantly associated with
prolonged duration of chest tube output. Smaller graft size
(P  .005), longer cardiopulmonary bypass time (P  .04),
and lower preoperative oxygen saturation (P  .004) were
significantly associated with increased volume of chest tube
output.
In addition to the risk factors listed, the univariate anal-
ysis showed that dominant right ventricular lesions and the
use of postoperative ACE inhibitors were significantly as-
sociated with prolonged duration, and younger age and
higher preoperative mean pulmonary artery pressure were
significantly associated with increased volume of pleural
drainage after the operation. We did not find weight at the
time of the operation, ventricular end-diastolic pressure,
presence of an accessory source of pulmonary blood flow,
postoperative mean pulmonary artery pressure, or presence
of a fenestration to be significantly associated with either
prolonged duration or excessive amount of pleural drainage.
Several different therapies were used for the treatment of
pleural effusions in patients with pleural drainage lasting
more than 2 weeks or draining at more than 20 mL · kg1
· d1. Diuretics were given to all patients. A low-fat diet
was used in 36 (95%) patients, and total parenteral nutrition
was used in 4 (10%) patients. Somatostatin therapy was
used in 2 (5%) patients. Eight (22%) patients with persistent
pleural effusions underwent cardiac catheterization for oc-
clusion of aortopulmonary collateral vessels.
Discussion
Postoperative pleural effusions are a major source of mor-
bidity after the Fontan procedure. Our study was undertaken
to identify select preoperative, operative, and postoperative
variables that increase the risk of persistent pleural effusions
after surgical intervention. Our data showed that 37% of
patients had prolonged duration, and 30% of patients had
increased volume of pleural drainage after the extracardiac
Fontan procedure. As determined by means of multivariate
analysis, lower preoperative oxygen saturation and the pres-
ence of postoperative infections were independent risk fac-
tors for prolonged duration of pleural drainage. Longer
cardiopulmonary bypass time, smaller graft size, and lower
preoperative oxygen saturation were independent risk fac-
tors for excessive volume of pleural drainage.
Some findings of our study are different from those of
the existing literature.3-5,8-30 There also does not seem to be
much consensus between other reported large series. The
objective of our study was to assess the risk factors for
persistent pleural effusions after the extracardiac Fontan
procedure. By focusing selectively on the patients who
underwent the extracardiac Fontan procedure, we had a
relatively homogenous patient population. We were also
able to exclude the effect of other Fontan modifications on
the outcomes selected. In addition, the patients included in
the study underwent surgical intervention over a relatively
short period of calendar time (5 years). This provided more
uniformity in the management of preoperative and postop-
erative care. We believe we were able to adequately assess
significant risk factors while conserving the power of our
data by reducing the effect of other confounding variables in
our study.
Three main mechanisms contribute to the development
of persistent pleural effusions after the Fontan procedure:
inflammatory, hydrostatic, and hormonal. The inflammatory
response results mainly from exposure to cardiopulmonary
bypass,17 causing increased capillary leakage and subse-
quent fluid retention. Increased hydrostatic pressure in the
Fontan circulation results from factors increasing the pul-
monary vascular resistance. Lack of atrioventricular syn-
chrony also contributes to this mechanism. The hormonal
mechanism involves activation of the renin-angiotensin sys-
tem,31 and more recent evidence suggests involvement of
the atrial natriuretic peptide and vasopressin.32
Lower preoperative oxygen saturation was an indepen-
dent risk factor for both prolonged duration and increased
volume of pleural drainage after surgical intervention. The
mechanism by which lower preoperative oxygen saturations
increase the risk of persistent pleural effusions after the
Fontan procedure remains speculative. Preoperative oxygen
saturation is a marker of total pulmonary blood flow, which
is dependent on pulmonary vascular resistance. On the basis
of the physiology of pulmonary blood flow, patients with
higher pulmonary vascular resistance are likely to have
lower preoperative saturations, and this might consequently
explain the occurrence of persistent pleural effusions.
Significant aortopulmonary collateral vessels and the
presence of an accessory source of pulmonary blood flow
might also influence the total pulmonary blood supply and,
consequently, the preoperative oxygen saturation. The role
of significant aortopulmonary collateral vessels in causing
persistent pleural effusions is controversial.9-13 Although
statistically insignificant, our data suggest that patients with
aortopulmonary collateral vessels are less likely to have
persistent pleural effusions. One previous study11 has cor-
related lower pulmonary vascular pressure with the devel-
opment of significant aortopulmonary collateral vessels.
This is the likely mechanism by which the presence of
aortopulmonary collateral vessels is correlated with reduced
duration of pleural effusions. The presence or absence of an
accessory source of pulmonary blood flow was not found to
be associated with persistent pleural effusions in our study.
Postoperative bacterial or fungal infections were also
shown to contribute to prolonged pleural effusions after
surgical intervention. However, because of the retrospective
Gupta et al Surgery for Congenital Heart Disease
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design of the study, we could not conclusively demonstrate
which factor of the 2 came first. Prolonged pleural effusions
after the Fontan procedure have been demonstrated to result
in loss of immunologic factors,14 including lymphocytes
and plasma proteins that might predispose to bacterial or
fungal infections after the procedure. Prolonged hospital
stay caused by persistent pleural effusions might also result
in exposure to iatrogenic infections. One previous study15
has demonstrated an increased risk of prolonged pleural
effusions after the Fontan procedure performed in the re-
spiratory viral season.
Prolonged cardiopulmonary bypass time was signifi-
cantly associated with increased volume of pleural drainage
after the operation. This finding is supported by several
previous studies.4,16,17 Longer cardiopulmonary bypass in-
fluences postoperative pleural drainage through exposure to
inflammatory sequelae. Reducing the exposure to cardio-
pulmonary bypass has been shown to facilitate more rapid
recovery and shorter hospital stay after the Fontan opera-
tion.17 The use of modified ultrafiltration18 has also been
reported to significantly reduce the incidence of postopera-
tive pleural and pericardial effusions, requirement for blood
products, and hospital stay after the Fontan procedure.
The smaller graft size used for construction of the extra-
cardiac baffle was also associated with an increased volume
of pleural drainage after the operation. We did not find other
reports in the literature relating the influence of graft size on
pleural effusions. Although smaller graft size was highly
correlated with lower age and weight at the time of the
operation, the multivariate analysis showed that the effect of
graft size was independent of the other 2 variables. Forty-
eight percent of patients with graft sizes of smaller than 18
mm had persistent pleural effusions compared with 25% of
patients with graft sizes of larger than 18 mm. We found a
statistically nonsignificant positive correlation between
smaller graft size and higher postoperative pulmonary artery
pressure after the operation. We speculate that this might be
the contributing mechanism for the effect of smaller graft
size on excessive pleural drainage.
The use of ACE inhibitors postoperatively was positively
associated with prolonged duration of pleural effusions in
the univariate analysis. There are conflicting reports in the
literature about the influence of ACE inhibitors on the
duration of pleural effusions after the Fontan procedure.19,20
ACE inhibitors influence pleural drainage after surgical
intervention through their action on the renin-angiotensin
axis, which has been shown to contribute to the occurrence
of prolonged pleural effusions after the Fontan procedure.21
The contradictory results we obtained could have been
related to patient selection factors in a retrospective study,
even though there was no statistically significant difference
between the patients treated with and without ACE inhibi-
tors in our data.
Dominant right ventricular lesions were also a risk factor
for prolonged duration of pleural drainage in the univariate
analysis. This finding has been previously reported.16,22
Although mortality after the Fontan procedure for hypoplas-
tic left heart syndrome has dramatically improved,16 it still
remains a risk factor for persistent pleural effusions.
Younger age at the time of the operation was significantly
associated with increased volume of pleural drainage after
the operation in the univariate analysis. Most previous stud-
ies have demonstrated that although age is a risk factor for
Fontan failure, it is not a risk factor for persistent pleural
effusions.12,15,23 Because our study only includes extracar-
diac Fontan procedures, our patient population might differ
slightly from those of other series, and this could be the
reason for our contradictory results.
Higher preoperative pulmonary artery pressure was also
significantly associated with increased volume of pleural
drainage after the operation in the univariate analysis. This
variable also has previously been reported as a risk factor
for Fontan failure24,25 after the operation but not for persis-
tent pleural effusions.15,26 It appears logical that higher
mean pulmonary artery pressure contributes to poor post-
operative hemodynamics with failure of the Fontan physi-
ology and persistent pleural effusions by means of a similar
mechanism.
Fenestration of the Fontan baffle has been reported to
significantly reduce the duration of pleural effusions in
several previous reports.27-30 Although the presence of fen-
estration was not found to significantly affect persistent
pleural effusions in our study, we do not routinely perform
fenestration of the extracardiac baffle at our institution. This
procedure is reserved for patients with higher-risk hemody-
namics. Hence our contradictory results might have been
biased by patient selection.
The most significant limitation to our study is that there
was no uniform protocol for management of persistent
pleural effusions after the Fontan operation. The criteria for
removal of chest tubes and evaluation of potential risk
factors were not standardized and were based mostly on
physician preference. These limitations might have con-
founded the evaluation of our main outcome measures and
potential risk factors. Additionally, the causal association of
these risk factors could not be adequately established be-
cause of the retrospective design of the study. Also, because
the study was focused on early postoperative outcome
alone, the correlation of these risk factors to intermediate
and long-term outcomes remains to be established. Finally,
we were unable to assess certain other variables that might
contribute to persistent pleural effusions, such as anatomy
of the pulmonary arteries, hormonal disturbances, and dia-
phragmatic paralysis, in the present study.
In summary, persistent pleural effusions are a major
source of morbidity after the extracardiac Fontan procedure,
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especially in view of the dramatically improved early sur-
vival. Certain patient- and procedure-related risk factors
influence the occurrence of this complication. These risk
factors can be used to predict which patients would have
persistent pleural effusions after the operation. We also
speculate that modification of some of these risk factors
might improve early postoperative outcomes.
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